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Abstract: Long-term oxygen therapy (LTOT) has become standard care for the treatment of patients
with chronic obstructive pulmonary disease (COPD) and other severe hypoxemic lung diseases.
The use of new portable O2 concentrators (POC) in LTOT is being expanded. However, the issue
of oxygen titration is not always properly addressed, since POCs rely on proper use by patients.
The robustness of algorithms and the limited reliability of current oximetry sensors are hindering the
effectiveness of new approaches to closed-loop POCs based on the feedback of blood oxygen saturation.
In this study, a novel intelligent portable oxygen concentrator (iPOC) is described. The presented
iPOC is capable of adjusting the O2 flow automatically by real-time classifying the intensity of a
patient’s physical activity (PA). It was designed with a group of patients with COPD and stable chronic
respiratory failure. The technical pilot test showed a weighted accuracy of 91.1% in updating the O2
flow automatically according to medical prescriptions, and a general improvement in oxygenation
compared to conventional POCs. In addition, the usability achieved was high, which indicated a
significant degree of user satisfaction. This iPOC may have important benefits, including improved
oxygenation, increased compliance with therapy recommendations, and the promotion of PA.
Keywords: COPD; oxygen concentrator; oxygen therapy; automatic oxygen concentrator; physical
activity; machine learning; respiratory medicine; portable oxygen concentrator; oxygen delivery
1. Introduction
Oxygen is a substantial element in the sustenance of human life. Of the hundreds of tasks that
oxygen performs in the human body, two stand out for their importance: detoxification and energy
production. However, some diseases affect the ability of the lungs to perform the gas exchange
necessary to incorporate oxygen into the bloodstream and to release carbon dioxide. In many situations,
extra oxygen is needed when the respiratory system cannot maintain an adequate pulmonary exchange
of physiological gases. This therapeutic use of supplemental oxygen is defined as oxygen therapy
and it aims at increasing the inspired oxygen fraction (FiO2). Therefore, when medically prescribed,
oxygen is a drug. Oxygen therapy is an established treatment, and it continues to be one of the most
important measures in the management patients with progressing chronic respiratory disease. In this
case, the main objective of oxygen therapy is to improve tissue oxygenation and to correct the severe
hypoxemia that these patients usually present with in the advanced stages of the disease [1,2]. The goal
is to maintain oxygenation levels above the range of respiratory failure, defined by an O2 blood partial
pressure [PaO2] > 60 mmHg, and an oxygen saturation measured by pulse oximetry [SpO2] > 90%.
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Currently, clinical applications for the use of oxygen have extended beyond the hospital setting.
When patients receive oxygen supplementation at home, the therapy is referred to as home oxygen
therapy (HOT). HOT provided as long-term oxygen therapy (LTOT), that is, used on a daily basis and
at least by 15 h per day, is recommended by current treatment guidelines since it has been shown to be
effective in increasing survival in patients with chronic obstructive pulmonary disease (COPD) and
respiratory failure [3–6]. In addition, ambulatory oxygen therapy improves physical performance in
patients with COPD [7].
Despite all these benefits of HOT for patients with respiratory failure, evidence that supports
the prescription of HOT in other chronic conditions associated with hypoxemia is limited [8].
While supplemental oxygen is valuable in clinical situations such as those aforementioned,
the inappropriate use of this therapy can be detrimental. Hypoxemia is defined as the decrease
in PaO2 below the normal limits, variable for the subject’s age (normal PaO2 ranges from 80 to
100 mmHg [9]). There is evidence that both hypoxemia and hyperoxemia, which results from exposure
to excessive O2 flows for a prolonged period of time, can have serious consequences for patients with
acute and chronic respiratory failure [10,11]. Although the risks for hypoxemia are well known [12],
there is growing evidence that excessive oxygen flow can be potentially harmful. In this regard,
hyperoxemia has been associated with increased hospital mortality among patients admitted to
intensive care units (ICUs) following cardiac arrest resuscitation [13]. In this regard, hyperoxemia
may be especially problematic in patients with COPD in the acute phase of exacerbation, because of
its association with hypercapnia [14,15] and its potential to mask the onset of a worsening in lung
function [10]. In addition, toxicity caused by hyperoxemia in some patients with COPD receiving
LTOT has received attention from researchers [16].
Notwithstanding this, all the scientific evidence supports the idea that the proper use of
supplemental oxygen therapy is an important factor that can positively influence clinical outcomes in
patients with respiratory failure and severe hypoxemia [17].
The administration of LTOT requires devoted delivery devices. The source of oxygen and the
equipment for its administration, which will depend on the patient’s profile, his/her movability, the
flow required, the time needed for oxygen therapy sessions, and above all, the proper correction of
SpO2 both at rest and during sleep or effort are also important factors [18].
Until recently, the most common way to deliver LTOT to patients has been by using static sources,
such as stationary oxygen concentrators or high-pressure cylinders. The shortcoming of such devices
is that they prevent the patient from wandering or leaving home while therapy is being received.
The heightened mobility and physical activity of these patients have resulted in the need for smaller,
lighter, and more autonomous portable oxygen devices [19]. For those reasons, a new generation of
portable, lightweight devices has emerged in recent years. These devices, known as portable oxygen
concentrators (POCs), have sufficient autonomy to enable the patient to live an active life outside
the home. Unlike classical gaseous or liquid oxygen devices, POCs produce their own oxygen by
removing nitrogen from atmospheric air. Before it goes into the concentrator through the inlet filter,
air is composed of 80% nitrogen and 20% oxygen. Firstly, the POC compresses the oxygen using a
compressor. The compressed air moves to a sieve bed of filters that separate the nitrogen from the
oxygen. Then, the oxygen, now at around 90%–95% purity, is stored in a product tank within the
device and is delivered to the patient via a delivery device (i.e., a nasal cannula).
POCs can deliver oxygen via continuous flow or pulse flow. Continuous flow units put out a
specific adjustable dose measured in litres per minute. Pulse units pulse air through a cannula with
each breath and their output is determined by the size of the individual pulse (millilitres per pulse)
and the patient’s respiratory rate.
It is accepted that the oxygen flow, normally delivered in fixed doses to patients in oxygen therapy,
is not always optimized [19]. In fact, the oxygen requirements of patients under LTOT vary depending
on the type, intensity and duration of the physical activity that is being carried out. Low blood oxygen
levels may cause short-term symptoms, such as dyspnoea, and physio-pathological organic changes,
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such as tachycardia, increased respiratory rate, arterial hypertension and, in the long term, serious
problems such as pulmonary hypertension and cor pulmonale, among others. On the other hand,
excessive levels of blood oxygen can cause hypercapnic encephalopathy in some patients. In this
regard, the patients receiving LTOT are generally instructed to adjust the oxygen flow according to
the activities of daily living. Oxygen flow is therefore routinely targeted to maintaining the desired
oxygenation range. However, this task places a burden on patients that often affects adherence to
therapy, and the existing methods of oxygen delivery may not be sufficient when the patient’s activity,
and therefore the demand of oxygen, increases [20]. It has been reported that patients with COPD and
moderate hypoxemia have frequent and eventually significant desaturations during activities of daily
living and at night [21].
Adapting oxygen therapy to dynamic patients’ needs appears to be a key challenge. Among the
primary goals of the dynamic and adaptive oxygen flow adjustment are: (a) the optimization of therapy
and safety by minimizing the number of desaturation episodes, preventing periods of hyperoxia and
hyperoxia [12]; (b) the customization of the oxygen flow to the individual needs of patients; and (c)
oxygen consumption optimization.
In traditional flow oxygen delivery, the titration of oxygen therapy is generally performed
manually by selecting the level of oxygen flow [22]. In LTOT, this manual adjustment of oxygen flow is
carried out by patients themselves to meet their changing needs. The current POCs have a manual flow
regulator that is adjusted by prescription to a specific level of flow measured in litres or pulses. Existing
flow regulators modify the flow mechanically, by manipulating a valve, or electronically, by means of a
keypad integrated into the device. However, the manually continuous adjustment of the oxygen flow
rate is a time-consuming task that requires experienced and trained patients [23], and this can lead to
the improper use of the device and consequently to a poor quality flow adjustment during the changing
daily activities, which is usually linked to unintended delays and periods of desaturation [24,25].
Given the advanced average age of patients with COPD under LTOT [26], the probability of inadequate
use of the device is significant.
Very recently, the abovementioned limitations led to the search for new physiological closed-loop
devices (PCLC) that timely adjust oxygen flow rates to the needs of patient automatically [22].
PCLC medical devices use one or several physiological sensors to manipulate a physiological variable
autonomously according to the guidelines given by clinicians [27]. Exponents of PCLC in respiratory
medicine are the novel intelligent portable oxygen concentrators. Most of the published articles on
technologies for PCLC in oxygen therapy for adults are from post-2010, indicating that these devices
are a relatively new field in the respiratory speciality. These devices may potentially optimize oxygen
therapy, reduce the workload of health professionals, minimise medical error, shorten health care costs,
and decrease mortality and morbidity [28,29].
Intelligent POCs include three main components: a system for monitoring the patient’s
oxygenation, an algorithm to estimate the O2 flow settings to achieve the targeted oxygenation
level, and an O2 source [20]. Figure 1 depicts the global architecture of a PCLC oxygen therapy device.
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oximeter) was used in 100% of studies on PCLC systems for automatic oxygen delivery in patients with
COPD [25]. Concerning the algorithms, the review concluded that continuous control by applying
conventional classical proportional-integral-derivative (PID), proportional-integral (PI), and rule-based
controllers have been proposed in the context of LTOT systems [30–33]. In these studies, the most
significant findings were related to the shortening of hypoxemia and hyperoxemia episodes when
PCLCs were used. However, a challenge in these algorithms is related to stability and robustness,
associated with the system capacity to discriminate between real abnormal oxygenation events and
ghost episodes caused by motion artefacts or a poor-quality oximetry signal. This major challenge has
not been overcome, and, at present, there are only a few commercial systems available (i.e., Optisat
AccuO2® [34], the O2 Flow Regulator® [33], and the FreeO2® [19]). The existing systems require
the patients to be continuously connected to a pulse oximeter, which becomes the primary source of
information for the algorithm. Current pulse oximetry technology is marked by the instability of the
sensor relating to movements or by the physiological delay in the measurements, which may reduce
its clinical effectiveness. Additionally, this technology presents very limited effectiveness in assessing
hyperoxia and promptly detecting respiratory depression [22]. Moreover, pulse oximeters are known
to be inaccurate in conditions that decrease arterial blood perfusion or cause the presence of elevated
concentrations of carboxyhaemoglobin (CoHb) and methaemoglobin (metHb).
As a consequence, the development of innovative physiological sensors and predictors of oxygen
desaturations to enable autonomous therapy and support its clinical validity is still an on-going
challenge [35].
In addition to technological matters, patient perceptions on usability and adequacy of POCs is an
issue. In a recent study, 51% of the patients under LTOT consulted reported oxygen problems related
to equipment malfunction, a lack of physically manageable portable systems, and a lack of portable
systems with high flow rates [36]. In that study, 44% of respondents referred to the limitations in
activities outside the home imposed by inadequate portable oxygen systems.
In summary, despite their potential and the existing end-users (patients) demand, PCLC oxygen
therapy devices are scarcely found in real clinical applications. The robustness of control algorithms,
the limited reliability of sensors, safety and usability issues, among others, can underlie this lack of
clinical implementation [25].
In this work, we propose an alternative approach that enables a POC to be transformed into
an intelligent POC (iPOC) to adjust the oxygen flow automatically in patients with COPD and
respiratory failure that receive LTOT. The proposed system is based on the automatic classification of
the intensity of the patient’s physical activity and can adjust the oxygen flow to individual real-time
needs autonomously. It is a transdisciplinary work, rooted in the field of respiratory medicine, with
contributions from electronics, control theory, computer science and artificial intelligence.
An external portable electronic system was designed and integrated into a commercially available
POC. The system comprised two units: 1) a sensor unit attached to the patient, that classifies the
physical activity in real-time; and 2) a receiver unit, interfaced to the POC, that adjusts the oxygen flow
according to the input from the sensor unit automatically. The algorithm for the automatic recognition
of physical activity was trained and validated using machine learning techniques. A circuit was
designed to gather data for personalizing models and to evaluate the system performance in a group
of patients with COPD and respiratory failure receiving LTOT.
The rest of the paper is organised as follows. Section 2 details the participants, materials, devices
and methodology applied to develop the iPOC system and to conduct the experiments. In Section 3,
the results achieved are presented and discussed. Finally, Section 4 captures the conclusions and
future works.
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2. Materials and Methods
2.1. System Architecture and Working Principle
Figure 2 shows the general outline of the proposed iPOC. The closed-loop control was implemented
using a SISO (Single Input - Single Output) controller [37]. The control law is defined by a lookup-table
controller. The oxygen flow level (output) corresponding to each state of physical activity intensity
(yn) was defined by the pulmonologists and personalised to the needs of each patient according to
conventional clinical assessment procedures [38]. The system automatically identifies the intensity
of the patient’s physical activity by classifying it into one of a 3-class scheme (sedentary, light, and
moderate). The intensity of physical activity detected in real-time is communicated to a control unit
connected to the POC, which is responsible for adapting the oxygen flow to the level previously
calibrated by the physician for each situation. Therefore, when an increase in the intensity of the
patient’s physical activity is detected, the system manages the automatic increase in oxygen flow.
Conversely, when the patient lowers the intensity of the physical activity, the device orders the flow to
be decreased to the predetermined level for that new condition. In addition, the automatic dosing
device can be deactivated by switching the system to the conventional manual mode. The proposed
system comprises a unit for estimating the intensity of the patient’s physical activity (sensor unit) and
unit for controlling the oxygen supplied flow (control unit). These units where designed iteratively
using a patient-centred approach. Each of these elements will be described in more detail in the
next subsections.
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Figure 2. The architecture of the proposed intelligent closed-loop portable oxygen concentrator (iPOC).
2.1.1. Sensor Unit
The sensor unit is a portable module placed on the patient’s chest. Ac elerometer- and
gyroscope-based physical onitoring syste s have been shown to be able to discriminate betwe n
different daily activities [39–42]. Each of these physical activities leads to a different level of energy
expenditure, and in patients under LTOT, to different oxygen flow requirements. For the estimation
of the intensity of physical activity, an inertial measurement unit (IMU) based on MEMs technology
was used. is I i cl a t ree-a is accel r t , a tri le- is r sc , r t .
The signals acquired by the IMU were proces ed using a microcontroller (MCU) and digital signal
proces ing techniques to extract features u eful for discrimination. A classification model, trained a d
vali ated using machine learning algorithms, automatically lassified th intensity of the activity and
transmitted this information wirelessly to the control unit.
The sensor unit incorporated a Mealy finite-state machine (FSM) after the classification stage as a
safety mechanism (Figure 3) to prevent abrupt changes in the flow of oxygen (e.g., change of state from
a sedentary level to a moderate one or vice versa).
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In order to conduct the research, two prototypes of the sensor unit were developed, each with
different purposes and requirements. The first prototype was designed to perform raw-data collection
using a µSD card during the training and internal validation of the machine learning models (Figure 4).
It was equipped with a SAM-D21 (ARM M0+ 32bits, 256KB Flash, 32KB RAM) microcontroller. An RGB
LED was added to show the device state (e.g., error state, standing state, starting data recording state
and recording data state).
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The second prototype was implemented to host the final trained classification model including the
FSM. It featured an ARM M0 (32bits, 128KB Flash and 24KB RAM) and wireless Bluetooth Low Energy
(BLE) communications. Both prototypes were equipped with the 9-axis MEMS sensor LSM9DS1,
which includes 3 digital acceleration channels (±2/±4/±8/±16 g linear acceleration full scale), 3 angular
rate channels (±245/±500/±2000 dps angular rate full scale), SPI/I2C serial interfaces, 16-bit data output
and programmable interrupt generators. In addition, an LPS25HB MEMS piezo-resistive pressure
sensor was used. The PS25HB barometer measurement range is from 260 to 1260 hPa. Pressure sensor
information showed poor sensitivity for real-time classification purposes and was not used in the
study. Both PCBs incorporated a 600 mAh lithium polymer (LiPo) battery, management connectors
and circuits. The housing of the final prototype was designed with a double patient fixation option:
nasal cannula tube fixation (Figure 5a) and thoracic elastic band fixation (Figure 5b).
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(a)                                          (b) 
Figure 5. Three-dimensional design of the embodiment of the final prototype of the sensor unit
including: (a) an adapter to the nasal cannula; (b) an adapter for a chest-band.
The sensor unit draws around 10 mA with 60 mA peaks when Bluetooth communications are used.
In the worst scenario, considering an average consumption of 30 mA and the 600 mAh battery, the unit
performs monitoring for about 14 h using the 600 mAh battery. This operating time is significantly
longer than that of the oxygen concentrator, which ranges from 2 to 5 h.
The sensor unit was placed in the chest of the user, just at the end of the sternum. It has been
reported that this location generates fewer motion artefacts due to movements compared to systems
placed on the wrist, ankle or the belt [43]. The unit was mounted to ensure that the Y-axis of the IMU
pointed at the head of the subject, and the Z-axis in the walking course. (Figure 6).
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2.1.2. Control Unit
The control unit receives the estimate of the intensity of the patient’s physical activity and
is responsible for adjusting the oxygen flow supplied to the patient according to the instructions
established during the process of tuning of the therapy. The control unit includes an MCU and wireless
communication capabilities, and interfaces directly with the POC. It was equipped with an ARM M0
(32bits, 128KB Flash and 24KB RAM), wireless BLE communications, an RGB LED, and a push-button
to activate the automatic mode in the POC (Figure 7). The unit was directly powered from the POC.
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Figure 7. The control unit implemented for communication with the sensor unit and for controlling the
portable oxygen concentrator. Header jumpers were used to personalize oxygen therapy settings and
push button to switch the portable oxygen concentrator operating mode (manual or automatic).
The control of the concentrator by the control unit was carried out by simulating physical pulses
to the increase and decrease buttons in the touch keyboard of the POC. As a consequence, the interface
between the control unit and the POC was implemented using a 5-pin connector that enabled the
power supply of the unit and the switching of the signals to increase or decrease the flow. In addition,
a 6-pin male connector was included to enable the personalisation of different oxygen levels settings
using header jumpers (see Table 1 and Section 2.1.2). As an example, the setting number 2 should be
selected (jumper P2 on) for a patient who requires, at 15 breaths per minute, a bolus volume of 12 mL at
rest, of 36 mL while doing light intensity activity, and of 60 mL when doing moderate intensity activity.
Table 1. Personalisation of oxygen therapy in the control unit. Seven different options were available.
Bolus volume (pulse setting 1 to 5) delivered to patient depending on the intensity of physical activity
ranges from 180 mL (pulse setting 1) to 900 mL (pulse setting 5).
Setting Pulse Setting according to Physical Activity Jumpers Setting
Sedentary Light Moderate P3 P2 P1
1 1 2 4 X
2 1 3 5 X
3 1 4 5 X X
4 2 4 5 X
5 3 4 5 X X
6 0 2 5 X X
7 0 1 4 X X X
The control unit presents the same power consumption as the sensor unit. It is powered from
the POC and causes a battery drain of 214 mAh, what supposes a decrease of about 12 min in the
concentrator operating time.
2.1.3. Portable Oxygen Concentrator
Inogen One G2 POC was used in the study (Figure 8). The Inogen One G2 delivers up to
900 mL/min of 90% oxygen and supports pulsed dose delivery [44]. This concentrator has five levels
for the adjustment of the oxygen needs. The oxygen dose applied to each patient in each situation
depended on the previous titration by the specialist.
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In general, this POC delivers 12 mL per bolus per flow setting at 15 breaths per minute (180 mL/min
per-flow setting). Table 2 summarizes the bolus volumes delivered at reference environmental
conditions. Slower breathing patients will receive larger boluses, and faster breathing patients will
receive smaller boluses.
Table 2. Bolus volumes delivered by Inogen One G2 at 20 ◦C at sea level at different breathing frequencies.
Pulse Setting
Pulse Volume (ml ± 10%)
15 Breaths per Minute 20 Breaths per Minute 25 Breaths per Minute
1 12 9 7.2
2 24 18 14.4
3 36 27 21.6
4 48 36 28.8
5 60 45 36.0
2.1.4. Communication Protocol
The units were programmed using the Arduino Integrated Development Environment (IDE).
The bidirectional communication between the sensor unit and the control unit takes place using
low-latency Bluetooth 4.0 (BLE) with 128-bit AES CCM (counter with cypher block chaining message
authentication code CBC-MAC) encryption/decryption without pairing. The messages are sent
encrypted with the serial number of the sending microcontroller and it is the receiver that uses the
serial number to decrypt the messages. The wireless control can be authenticated through toasts for
the confirmation of the desired operations and also tracked through timestamps. BLE remains in
sleep mode at all times, except when participating in a data exchange, which reduces overall energy
consumption. In this manner, the sensor unit only sends messages when there is a change in physical
activity intensity.
2.2. Study Design and Participants
A total of 18 volunteers (Table 3) were recruited for this study at the Pneumology, Allergy,
and Thoracic Surgery Unit of the University Hospital Puerta del Mar de Cadiz (Spain) (14 male,
average age 66.9 ± 12.8 years, range 60–93 years, average body mass index (BMI) 27.00 ± 3.6 kg/m2).
The participants selected had a diagnosis of COPD and stable chronic respiratory failure, and were
receiving LTOT and using a POC.
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Table 3. Demographic and clinical data for patients in the internal validation group.
Characteristics Data *
N 18
Male/Female 14/4 (77.7%/22.3%)
Age (years) 66.9 ± 12.8 (60–93)
51–60 5.6% (1)
61–70 44.4% (8)
71–80 16.7% (3)
81–90 33.3% (6)
BMI (Kg/cm2) 27.0 ± 3.6
LTOT history (months) 22.1 ± 18.1
POC history (months) 19.5 ± 13.2
Daily hours using the POC 2.3 ± 1.0
mMRC dyspnoea baseline level 2.6 ± 0.5
FEV1/FVC 0.5 ± 0.2
BMI: Body mass index; LTOT: long term oxygen therapy; POC: portable oxygen concentrator; mMRC: Modified
Medical Research Council scale; FEV1/FVC: forced expiratory volume in 1-s to forced vital capacity ratio. * Results
expressed as mean ± SD, except where otherwise indicated.
Exclusion criteria included any organic comorbidity that could cause or contribute to exertional
dyspnoea that would hinder the realization of the circuit (cardiovascular diseases, metabolic or other
associated respiratory diseases), COPD exacerbation within the six weeks before the enrolment or any
disease that could limit the physical activity of the patient (e.g., neuromuscular or skeletal diseases).
The general fragility (i.e., difficulty in walking or lack of autonomy) that could substantially prevent the
patient’s participation in the study was also considered an exclusion criterion, as well as the diagnosed
mental incapacity. Prior to enrolment, all participants signed an informed consent form. The local
ethics committee approved the study protocol.
In order to train and validate the machine learning models, an accurate reference (gold standard)
was required. For this reason, the experiments were carried out in the hospital, where it was
possible to observe participants closely, perform accurate references and do it under medical and
technical supervision.
During a single visit to the hospital, participants were first interviewed. The Mini-Mental state
examination (MMSE) was conducted and dyspnoea was measured before and after the test using the
Modified Medical Research Council scale (mMRC). Then, subjects were fitted with the designed sensor
unit and the Inogen One G2 portable oxygen concentrator. The participants followed the designed
study protocol that started with an initial period of three minutes at rest, in a seated position. Next,
participants were asked to walk, following the circuit illustrated in Figure 9, for 12 min.
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The circuit included sections for walking, climbing and descending stairs. Participants were
asked to exercise a gait pattern similar to that maintained in their daily activity in order to capture
representative conditions of the activities performed in daily free-living conditions. Along the route,
chairs were arranged for the subject to make stops when he/she considered necessary. Throughout
the experiment, there were no restrictions on the participant’s body movements. The final activity
consisted of sitting for three minutes.
During each test, the stop and start times of each activity were noted and a label was assigned to
each period of time. In addition, the number of user interactions with the POC, the flow level selected
by the patient in each section of the circuit, the number of rest episodes (seated) of the participant, the
oxygen saturation and the heart rate (measured using a Nonin WristOx2® Model 3150 pulse-oximeter),
and the distance walked were recorded.
2.3. Automatic Classification of the Intensity of Physical Activity
2.3.1. Daily Activities in Patients with COPD
The metabolic equivalent of tasks (MET) expresses the energy cost of physical activities and is
defined as the ratio of the work metabolic rate to the resting metabolic rate, expressed in kcal/kg/hour.
One MET is considered to be equivalent to the energy cost during quiet sitting. In addition, a MET
can also be defined as the amount of oxygen consumed while sitting at rest, measured in ml/kg/min.
In this case, one MET is equal to the oxygen cost of sitting quietly, equivalent to 3.5 mL/kg/min. A third
definition relates MET to the rate of energy produced per unit surface area of an average person seated
at rest, expressed in W/m2 [45].
Different intensity physical activities entail different energy costs and therefore require varying
levels of oxygen consumption. Table 4 describes the physical activities considered in this study. High
intensity physical activities were not addressed since they are not expected in patients with COPD and
respiratory failure. As described above, the amount of oxygen supplement required for each patient
according to the intensity of the physical activity is titrated by the specialist at the initiation of therapy.
A change in the intensity of the physical activity performed by the patient poses a need for updating
the amount of oxygen provided by the POC [46].
Table 4. Activities, grouped by intensity, associated MET, and the number of instances.
Intensity Activity METs (W/kg) Number of Instances
Sedentary
Sitting
Standing
Lying
1.3 2160
Light Walking 2 3115
Moderate Walking upstairsWalking downstairs 3.5–5 550
Total 5825
MET: The metabolic equivalent of task.
2.3.2. Data Processing and Features Extraction
The data from the accelerometer and from the gyroscope (X, Y and Z axes) were collected at a
sampling rate of 25 Hz. The acceleration signals were divided into windows of 3 s (75 samples) without
overlap, which was considered enough to capture significant properties of the signal. Activities of
different intensity were identified from annotated labels.
In order to remove the DC component in the IMU signals, a high-pass filter with a cut-off frequency
of 0.15 Hz was applied. The filtering was implemented using a low-pass IIR filter whose output was
subtracted from the original signal.
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For each of the time windows, 98 time-domain features were extracted from the six filtered
acceleration and gyroscope signals. The explored features are detailed in Table 5. Features from
the frequency and non-linear domains were excluded to reduce the computational burden in the
microprocessor when implementing the real-time classification model.
Table 5. Initial feature set.
Feature Set (Accelerometer + Gyroscope) Features
RMS, standard deviation, absolute mean 18
Mean of the derivative 6
Pairwise correlations 6
Simplified energy 6
Moments (skewness, kurtosis, median) 18
Min, max, difference between max and min 18
Interquartile range 6
Signal magnitude vector (mean, standard deviation, median,
skewness, kurtosis) 10
Signal magnitude vector (interquartile range, max, min, the
difference between max and min) 8
Signal magnitude area 2
Total 98
RMS: Root mean squared.
2.3.3. Features Selection
In order to improve the computational efficiency and reduce the generalization error of the model
by removing irrelevant features, a wrapper feature selection approach was followed. The space of
attribute subsets was searched by greedy hill-climbing augmented with a backtracking facility [47].
The search started with an empty set of attributes and search forward. The number of consecutive
non-improving nodes allowed before terminating the search was 5. The feature selection algorithm
operated in tandem with different machine learning classifiers and classification accuracy at each step
was compared. The entire training-internal validation process is shown in Figure 10.
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2.3.4. Classification and Internal Validation
A binary hierarchical classification structure (BHC) with two classifiers was chosen due to its
computational simplicity [48]. Figure 11 shows the proposed architecture of a hierarchical classifier
that requires two pairwise classifiers arranged as a binary tree with three leaf nodes, one for each class,
and two internal nodes, each with its own feature space. Each of the two internal nodes consisted of a
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classifier and a set of features specific to it. The coarse separation between classes (sedentary vs active
intensity of physical activity) occurred at the upper level in the hierarchy and a finer classification
decision (light vs moderate intensity) at a lower level [49]. The architecture had a balanced binary
hierarchical structure, in which the two meta-classes at each node had the same number of classes.
For this study, decision trees (DT), Linear Discriminant Analysis (LDA), Logistic Regression Classifier
(LR), Support Vector Machines (SVM), and Radial Basis Function (RBF) classifiers were evaluated as
candidates for each of the internal nodes.Sensors 2020, 20, x FOR PEER REVIEW 13 of 22 
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Figure 11. e proposed binary hierarchical classifier (BHC) applied to the classification of the intensity
of physical activity. Given that the cl ssifier operates with three class s, its structure has 2 internal
odes and 3 leaf nodes. Each internal node is comprised of a set of features (ψi) and a cl ssifier (φi).
Each node n is associated with a set of classes. In this study, classes are defined as: 0 = sedentary
physical activity; 1 = light-intensity physical activity; and 3 = moderate-intensity physical activity.
The FSM machine described in Section 2.1.1 was added to the BHC as an output layer to enhance
safety. Each classifier was trained with leave-one-subject-out cross-validation (LOSO-CV) scheme,
where data from 17 participants were used for training the classifier, and the remaining participant
data for evaluating the model performance. This process was repeated 18 times so that each participant
was used once for validation.
Several weighted metrics were used to measure model performance: precision, recall, and
F1-measure, defined as the weighted average of precision and recall. Additionally, sensitivity (Se),
specificity (Sp), and the geometric mean of sensitivity and specificity (G) were estimated. Finally, the
receiver operating characteristic (ROC) curve was computed and the area under the curve (AUC) for
each class was estimated. Signal processing and model training and validation were performed using
MATLAB software (Mathworks Inc., Natick, MA, USA) and DTREG predictive modelling software.
2.4. echnic l Pilo Test
In the final stage, five participants went through the circuit designed during the previous phase,
using the POC in automatic mode (iPOC). Demographic and clinical data for these patients are shown
in Table 6.
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Table 6. Demographic and clinical data for patients in the technical pilot test.
Characteristics Data *
N 5
Male 5 (100 %)
Age (years) 72.2 ± 6.5
BMI (Kg/cm2) 28.4 ± 6.0
LTOT history (months) 27.6 ± 25.7
POC history (months) 22.8 ± 15.5
Daily hours using the POC 4.2 ± 2.4
mMRC (baseline dyspnoea index) 2.6 ± 0.5
FEV1/FVC 0.5 ± 0.2
BMI: Body mass index; LTOT: long term oxygen therapy; POC: portable oxygen concentrator; mMRC: Modified
Medical Research Council scale; FEV1/FVC: forced expiratory volume in 1-s to forced vital capacity ratio. * Results
expressed as mean ± SD, except where otherwise indicated.
This feasibility pilot was conducted with the purpose of examining technical and usability issues,
and the differences in the changes in blood oxygen saturation with respect to the circuit performed in
manual mode. Special attention was paid to the number of oxygen desaturation episodes and to the
maximum and minimum SpO2 values during the test.
2.5. Usability
After each experiment, a semi-structured interview was conducted with the involved patient,
in order to obtain information regarding the usefulness, ease of use and expectations of the participant.
In addition to the 18 patients enrolled, 15 additional patients under LTOT were interviewed by
phone, in order to have a more significant sample.
Three main questions were asked in the interview:
1. Do you consider a system such as the one proposed to be necessary?
2. Would the automatic concentrator promote your out-of-home activities?
3. In your daily use of the concentrator, do you forget to adjust the recommended dose of O2 when
the intensity of your physical activity varies?
In questions 1 and 2, the subject was asked to describe his/her degree of agreement on a Likert
scale from 1 through to 5, with the strongest positive agreement being 5. To assess usability, the System
Usability Scale (SUS) was used in the technical pilot test. SUS is a 10-item questionnaire with 5 response
options ranging from strong agreement to strong disagreement. The SUS possible values range from 0
to 100 [50].
3. Results and Discussion
3.1. Model Training and Internal Validation
The dataset used in this study phase included 18 patients, and three different classes with 2160
epochs of sedentary, 3115 epochs of light activity and 550 epochs of moderate activity. Figure 12
illustrates the signals acquired in a time window during different activities along with a test.
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Figure 12. Signals acquired during one of the experiments in the hospital, with the patient walking
the circuit designed for the physical test. (a) 3-axis accelerometer signals; (b) 3-axis gyroscope signals;
(c) barometer signal. Red vertical lines indicate changes in activity (walking on level, going upstairs,
going downstairs).
Table 7 shows the dimensions of the feature set that resulted from the wrapper-based Sequential
Feature Selection (SFS) approach for each of the explored models and classifiers.
Table 7. The optimal feature set obtained from Wrapper-based feature selection for the classifiers φ1
and φ2.
Method Selected Features forφ1 Selected Features forφ2
LR 8 17
J48 4 14
SVM 15 14
LDA 9 20
MLP 11 12
LR: logistic regression; J48: C4.5 decision tree; SVM: support vector machines; LDA: linear discriminant analysis;
MLP: multilayer perceptron.
Table 8 shows the model performance achieved by classifiers φ1 and φ2, respectively, using
the selected feature set for each trained and validated algorithm. In the case of φ2, and given the
large imbalance between classes, instances of light activity were weighted in order to balance target
categories. The weights were adjusted so that the sum of the weights for the instances within each
target category was the same.
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Table 8. Performance metrics of classifiers φ1 and φ2 for each cross-validated machine
learning algorithm.
Method Accuracy F1-Measure Se Sp G AUC
φ1 φ2 φ1 φ2 φ1 φ2 φ1 φ2 φ1 φ2 φ1 φ2
LR 94.54 91.86 95.60 64.71 95.70 51.16 93.38 98.81 94.53 71.10 0.98 0.85
J48 96.45 74.72 96.98 74.15 96.76 72.55 95.97 76.89 96.36 74.69 0.98 0.74
SVM 97.13 88.49 97.92 61.18 97.44 35.82 96.62 97.78 97.03 59.18 0.99 0.81
LDA 95.30 84.01 95.93 79.25 93.87 75.09 97.36 85.59 95.60 80.17 0.99 0.88
MLP 96.02 77.24 96.62 77.58 96.31 78.73 95.60 75.76 95.95 77.23 0.99 0.85
LR: logistic regression; J48: C4.5 decision tree; SVM: support vector machines; LDA: linear discriminant analysis;
MLP: multilayer perceptron; Se: Sensitivity; Sp: specificity; G: geometric mean of sensitivity and specificity; AUC:
area under the receiver operating characteristic curve (ROC) curve.
The results show that the φ1 classifier implemented using SVM was able to discriminate between
sedentary and active physical activity with a maximum value of F1-measure, G, and AUC of 97.92%,
97.03% and 0.99 respectively. In the case of the φ2 classifier, designed to discriminate between light
and moderate-intensity physical activities, maximum F1-measure, G and AUC were 79.25% (LDA),
97.13% (SVM) and 0.99 (SVM, LDA, MLP) respectively. The lower performance shown by classifier
φ2 is explained by the difficulty in discriminating between up and downstairs activities, which has
already been reported in other studies.
According to the results found, the LDA model, which demonstrated a better compromise between
sensitivity and specificity, and the higher AUC, was chosen for implementing the classifier φ2 in the
hardware. For classifier φ1, the J48 decision tree was chosen for the hardware deployment. Although
the SVM algorithm obtained better results in terms of G, it was discarded given that the differences in
performance were minimal and the computational cost of the SVM and its associated feature space
was significantly higher.
Figure 13 shows the Receiver Operation Characteristics (ROC) curves for each class and both
classifications approaches.Sensors 2020, 20, x FOR PEER REVIEW 16 of 22 
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Figure 13. Receiver Operating Char cteristics (ROC) Curves for selected models. The blue line
repres nts he ROC curve for the J48 model. The green line shows the ROC curve for the J48 classifier.
Table 9 illustrates the confusion matrix and the performance metrics for the build two stages of
classification procedure (BHC). The BHC was able to achieve a weighted-F1 measure of 85.9% with
weighted-precision and weighted-recall of 85.9%, and 86.1%, respectively.
During the completion of the circuit, the participants had to manually adjust the oxygen flow
several tim s du ing the route. The total number of adjustments required for the rounds completed
was 96. By contrast, participan s only manipulated the oxygen concentrator to suit the needs of
O2 demanded by the physical activity performed on 17 occasions, which showed underuse (only
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17.7% of needed adjustments were carried out) of the device that could potentially lead to oxygen
desaturation events.
Table 9. Performance metrics for the binary hierarchical classification structure for each of the levels of
intensity of physical activity.
Predicted Performance
True
S Other Precision Recall Accuracy F1-Measure
S 2073 77
95.4% 96.4% 97.0% 95.9%Other 101 3666
L Other
L 1569 335
76.1% 82.4% 85.9% 79.1%Other 493 3466
M Other
M 1393 470
82.9% 74.8% 86.9% 78.6%Other 288 3642
S: Sedentary; L: light intensity of physical activity; M: moderate intensity of physical activity.
3.2. Technical Pilot Test
The technical pilot test was carried out in a controlled environment in the hospital. The participants
walked the same circuit designed for data collection for model training and internal validation.
Figure 14 shows one of the participants during the test carrying the POC and the auxiliary units
designed for its automation.
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Figure 14. A participant using the automatic portable oxygen concentrator during the technical
pilot test.
10 synthesizes the results obtained by the BHC using the sam performance etrics applied
for internal validation.
Table 10. Weighted performance metrics of the binary hierarchical classification structure in the
technical pilot test.
Accuracy F1-Measure Precision Recall
91.1% 76.6% 74.9% 83.6%
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Again, the accuracy achieved is high (91.1%) but conditioned by the errors in the classification
of the activities up/downstairs. These errors are caused by the inherent difficulty in classifying these
tasks, and by the different pattern in each patient’s gait, which depends on their physical condition.
As a general rule, patients with COPD and respiratory failure who are receiving LTOT avoid using
long flights of stairs, thus errors made in this regard cannot be considered critical in a real-life scenario.
Table 11 shows a comparison of the results for changes in blood oxygen saturation for each of
the five participants during manual mode (conventional use of the device) and automatic mode tests
(proposed iPOC).
Table 11. Changes in blood oxygen saturation levels during the tests performed using the conventional
portable oxygen concentrator (POC) and the proposed intelligent POC (iPOC).
Mode Automatic POC (iPOC) Manual POC
Subject S1 S2 S3 S4 S5 S1 S2 S3 S4 S5
SpO2 events 2 1 1 2 3 3 3 6 1 2
Mean SpO2 89.5 92.2 89.1 94.7 87.1 88.6 90.4 86.1 91.5 89.5
min (SpO2) 77.0 87.0 85.0 89.0 81.0 80.0 86.0. 75.0 81.0 93.0
CT90 50.1 18.8 70.9 8.4 73 62.9 33.1 91.7 20.9 60.6
CT85 34.9 0.0 0.0 0.0 27.6 17.4 0.0 33.9 2.8 6.3
CTxx: time spent with SpO2 < xx%.
An overall reduction in the number of desaturation events can be appreciated in four out of the
five subjects. In the same four patients, the average blood oxygen saturation values were increased
with respect to the POC test in manual mode. In the same way, the minimum blood saturation values
were also improved. The cumulative time spent with SpO2 below 90% (CT90) and 85% (CT85) again
showed a generally better response when the iPOC was used.
Subject 5 deserves a special mention. He went around the circuit with reduced mobility due to the
use of a crutch as a result of an episode of low back pain. Additionally, he showed signs of exacerbation
within few days after the test. Some authors have detected significantly decreased saturation in the
period of seven days preceding exacerbation [51], so we think that the result of the test could have
been biased by these factors.
Figure 15 illustrates the change in blood oxygen saturation pattern on exertion for one of the
participants. The stabilization of SpO2 values, the reduction in the number of desaturation events,
and the higher mean value obtained with the use of the proposed system can be clearly observed.
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daily living activities in response to higher oxygen de is one, in conventional POCs, m nually
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to the change in physical activity intensity often leads to desaturation episodes [24].
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3.3. Usability
Table 12 presents a synthesis of the results obtained in the semi-structured interview with the
participants in the initial phase.
Table 12. Results from the semi-structured interview.
Question Average Likert Score
1. Do you consider a system such as the one proposed to be necessary? 5 ± 0 (33)
2. Would you the automatic concentrator promote your out-of-home activities? 5 ± 0 (33)
3. In your daily use of the concentrator, did you forget to adjust the
recommended dose of O2 when your degree of physical activity varies?
• Yes
• The patient consciously does not adapt the flow
• The patient ignores that he has to adjust it
51.5% (17)
30.3% (10)
18.2% (6)
All the patients interviewed considered that a system capable of automatically regulating the
oxygen flow in the concentrator was necessary. They also felt that such a system would help increase
physical activity outside the home. The high percentage of patients who admit to forgetting to adjust
the concentrator when faced with changes in physical activity intensity (51.5%) is noteworthy. Similarly,
the percentage of patients who consciously skip the adjustment of the oxygen flow is outstanding.
Finally, the average SUS score calculated after the technical pilot test was 79 ± 11.4. There was one
participant that had an average SUS score of 95, followed by scores of 85 (1/5), 75 (2/5), and 65 (1/5).
In the research, the average SUS value is 68, which can be considered a benchmark. The achieved value
of 79 indicates significantly better usability than average [52].
4. Conclusions
The long-term benefits of oxygen have been proven since the 1980s in certain respiratory conditions
such as COPD. Very recently, future research in oxygen therapy has been pointed at developing and
evaluating new models for therapeutic oxygen patient education and improving portable oxygen
devices [53]. It has been reported that, when compared to the conventional POCs, the closed-loop
POCs can maintain higher saturation levels, spend less time below the target saturation, and save
O2 resources [25]. The correction of exercise hypoxemia in lung diseases like COPD is crucial and
challenging [54], and automatic POCs can contribute to the individualized adjustment of oxygen flow.
Currently, the challenge of designing closed-loop portable devices which are able to adjust O2
flow automatically is being faced by mainly using indirectly measured blood oxygen saturation as
a process variable to close the loop. However, the robustness of control algorithms and the limited
reliability of current oximetry sensors are hindering the effectiveness of this approach.
In line with all the above-mentioned factors, this study presents the proof of concept of an
alternative approach: a system to transform a conventional POC into a closed-loop controlled device
capable of automatically self-adjusting, in real time, the oxygen flow supplied to the patient according
to the intensity of the physical activity carried out by the user under LTOT.
A sensor unit capable of detecting the physical intensity developed by the patient (in real time)
has been developed and evaluated. This sensor unit can wirelessly connect to the POC for the
self-adjustment of the oxygen flow. The system has been designed with the flexibility to customize
up to seven different oxygen therapy profiles. The developed iPOC was tested with a widely used
commercial POC unit. For this purpose, a treadmill circuit was designed that included basic physical
activities most common in the daily practice of elderly patients with respiratory disorders. Different
models were trained and validated using artificial intelligence techniques, a wrapper approach,
98 time-domain features, and data from 18 patients with COPD and respiratory failure. A final
meta-classifier (BHC) was designed and deployed in the sensor unit to operate in real-time. A weighted
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accuracy of 91.1% was achieved in the technical pilot test with five patients. A reduction in the number
of desaturation events was achieved in 80% of patients as well as improved minimum and average
blood oxygen saturation values compared to the POC in manual operating mode. In these cases, CT90
and CT85 also showed a promising better response when the iPOC was used. Finally, all interviewed
patients (N = 33) considered that the proposed iPOC satisfied them, and could promote their physical
activity outside the home.
Among the limitations of this study were those related to hypoxia. In this regard, the combination
of the proposed system with the novel oxygen reserve index (ORI) included in the new generation of
pulse oximeters that use multi-wavelength pulse co-oximetry might improve oxygen titration and
enable the prevention of unintended hyperoxia [55].
A closed-loop control system, like the proposed iPOC, has clear potential benefits, including
improved oxygenation regardless of physical activity and enhanced patient follow-up and compliance
with therapy recommendations. In addition, closed-loop oxygen supply systems have shown that they
can potentially reduce medical error, improve morbidity and mortality, and reduce care costs [22].
Future research steps include the miniaturization of the sensor unit, expanding the study sample,
and the home monitoring of the patients while using IPOC during daily tasks in an unsupervised
environment, in order to obtain clinical evidence of the impact that this approach may have on the
targeted patient population.
5. Patents
DSM and ALJ are the inventors of the utility model ES U201831680 with the title ‘Automatic
flow-metering device for oxygen therapy equipment’.
Author Contributions: Conceptualization, D.S.-M. and A.L.-J.; methodology, D.S.-M. and A.L.-J.; software, A.L.-D.
and D.S.-M.; validation, P.M.-Z., A.L.-J., A.L.-D. and D.S.-M.; formal analysis, A.L.-D. and D.S.-M.; investigation,
A.L.-J., P.M.-Z., A.L.-D. and D.S.-M.; writing—original draft preparation, D.S.-M.; writing—review and editing,
A.L.-J., A.L.-D., and D.S.-M.; visualization, A.L.-D. and D.S.-M.; supervision, D.S.-M.; project administration,
D.S.-M.; funding acquisition, D.S.-M. All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by grants from“Consejería de Salud y Familias de la Junta de Andalucía” and
“Iniciativa Territorial Integrada [ITI] 2014-2020 para la provincia de Cádiz” (PI-0006-2017); and by “Consejería de
Salud y Familias de la Junta de Andalucía” (PIN-0053-2017).
Acknowledgments: We want to thank the company Nippon Gases for the loan of the portable oxygen therapy
concentrator to carry out some of the experiments conducted in this research.
Conflicts of Interest: DSM and A.L.-J. are inventors of the utility model ES U201831680 with the title ‘Automatic
flow-metering device for oxygen therapy equipment’. A.L.-D. and P.M.-Z. have no conflict of interest.
Ethical Statement: All subjects gave their informed consent for inclusion before they participated in the study.
The study was conducted in accordance with the Declaration of Helsinki and the protocol was approved by the
Research Ethics Committee of Cadiz.
References
1. Lacasse, Y.; Tan, A.-Y.M.; Maltais, F.; Krishnan, J.A. Home Oxygen in Chronic Obstructive Pulmonary Disease.
Am. J. Respir. Crit. Care Med. 2018, 197, 1254–1264. [CrossRef] [PubMed]
2. O’Driscoll, B.R.; Howard, L.S.; Earis, J.; Mak, V. BTS guideline for oxygen use in adults in healthcare and
emergency settings. Thorax 2017, 72, ii1–ii90. [CrossRef] [PubMed]
3. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic
Obstructive Lung Disease (GOLD). Available online: http://goldcopd.org/ (accessed on 1 January 2020).
4. Celli, B.R.; MacNee, W. Standards for the diagnosis and treatment of patients with COPD: A summary of the
ATS/ERS position paper. Eur. Respir. J. 2004, 23, 932–946. [CrossRef] [PubMed]
5. Nocturnal Oxygen Therapy Trial Group. Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic
Obstructive Lung Disease. Ann. Intern. Med. 1980, 93, 391. [CrossRef]
Sensors 2020, 20, 1178 21 of 23
6. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor
pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council
Working Party. Lancet 1981, 317, 681–686. [CrossRef]
7. Bradley, J.M.; Lasserson, T.; Elborn, S.; MacMahon, J.; O’Neill, B. A Systematic Review of Randomized
Controlled Trials Examining the Short-term Benefit of Ambulatory Oxygen in COPD. Chest 2007, 131, 278–285.
[CrossRef]
8. Casaburi, R. Long-Term Oxygen Therapy: The Three Big Questions. Ann. Am. Thorac. Soc. 2018, 15, 14–15.
[CrossRef]
9. Samuel, J.; Franklin, C. Hypoxemia and Hypoxia. In Common Surgical Diseases; Springer: Berlin/Heidelberg,
Germany, 2008.
10. Branson, R.D.; Robinson, B.R.H. Oxygen: When is more the enemy of good? Intensive Care Med. 2011, 37,
1–3. [CrossRef]
11. Mach, W.J.; Thimmesch, A.R.; Pierce, J.T.; Pierce, J.D. Consequences of Hyperoxia and the Toxicity of Oxygen
in the Lung. Nurs. Res. Pract. 2011, 2011, 1–7. [CrossRef]
12. Cameron, L.; Pilcher, J.; Weatherall, M.; Beasley, R.; Perrin, K. The risk of serious adverse outcomes associated
with hypoxaemia and hyperoxaemia in acute exacerbations of COPD. Postgr. Med. J. 2012, 88, 684–689.
[CrossRef]
13. Kilgannon, J.H. Association Between Arterial Hyperoxia Following Resuscitation From Cardiac Arrest and
In-Hospital Mortality. JAMA 2010, 303, 2165. [CrossRef] [PubMed]
14. Austin, M.A.; Wills, K.E.; Blizzard, L.; Walters, E.H.; Wood-Baker, R. Effect of high flow oxygen on mortality
in chronic obstructive pulmonary disease patients in prehospital setting: Randomised controlled trial. BMJ
2010, 341, c5462. [CrossRef] [PubMed]
15. Sassoon, C.S.; Hassell, K.T.; Mahutte, C.K. Hyperoxic-induced hypercapnia in stable chronic obstructive
pulmonary disease. Am. Rev. Respir Dis 1987, 135, 907–911. [CrossRef] [PubMed]
16. Croxton, T.L.; Bailey, W.C. Long-term oxygen treatment in chronic obstructive pulmonary disease:
Recommendations for future research: An NHLBI workshop report. Am. J. Respir. Crit. Care Med.
2006, 174, 373–378. [CrossRef]
17. Brill, S.E.; Wedzicha, J. A Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease.
Int. J. Chron. Obstruct. Pulmon. Dis. 2014, 9, 1241–1252.
18. McCoy, R.W. Options for home oxygen therapy equipment: Storage and metering of oxygen in the home.
Respir. Care 2013, 58, 65–81. [CrossRef]
19. Lellouche, F.; L’Her, E. Automated Oxygen Flow Titration to Maintain Constant Oxygenation. Respir. Care
2012, 57, 1254–1262. [CrossRef]
20. Claure, N.; Bancalari, E. Automated closed loop control of inspired oxygen concentration. Respir. Care 2013,
58, 151–161. [CrossRef]
21. Casanova, C.; Hernández, M.C.; Sánchez, A.; García-Talavera, I.; De Torres, J.P.; Abreu, J.; Valencia, J.M.;
Aguirre-Jaime, A.; Celli, B.R. Twenty-four-hour ambulatory oximetry monitoring in COPD patients with
moderate hypoxemia. Respir. Care 2006, 51, 1416–1423.
22. Mayoralas-Alises, S.; Carratalá, J.M.; Díaz-Lobato, S. New Perspectives in Oxygen Therapy Titration:
Is Automatic Titration the Future? Arch. Bronconeumol. 2019, 55, 319–327. [CrossRef]
23. Dunne, P.J. Long-term oxygen therapy (LTOT) revisited: In defense of non-delivery LTOT technology. Rev.
Port. Pneumol. 2012, 18, 155–157. [CrossRef] [PubMed]
24. Dunne, P.J.; MacIntyre, N.R.; Schmidt, U.H.; Haas, C.F.; Jones-Boggs Rye, K.; Kauffman, G.W.; Hess, D.R.
Respiratory Care Year in Review 2011: Long-Term Oxygen Therapy, Pulmonary Rehabilitation, Airway
Management, Acute Lung Injury, Education, and Management. Respir. Care 2012, 57, 590–606. [CrossRef]
[PubMed]
25. Sanchez-Morillo, D.; Olaby, O.; Fernandez-Granero, M.A.; Leon-Jimenez, A. Physiological closed-loop control
in intelligent oxygen therapy: A review. Comput. Methods Programs Biomed. 2017, 146, 101–108. [CrossRef]
[PubMed]
26. British Lung Foundation: Chronic Obstructive Pulmonary Disease (COPD) Statistics. Available online:
https://statistics.blf.org.uk/copd (accessed on 1 January 2020).
Sensors 2020, 20, 1178 22 of 23
27. International Electrotechnical Commission. IEC 60601-1-10 Medical Electrical Equipment–Part 1-10: General
Requirements for Basic Safety and Essential Performance–Collateral Standard: Requirements for the Development of
Physiologic Closed-Loop Controllers; International Electrotechnical Commission: Geneva, Switzerland, 2007.
28. Dumont, G.A. Feedback control for clinicians. J. Clin. Monit. Comput. 2014, 28, 5–11. [CrossRef]
29. Lellouche, F.; Lipes, J.; L’Her, E. Optimal oxygen titration in patients with chronic obstructive pulmonary
disease: A role for automated oxygen delivery? Can. Respir. J. 2013, 20, 259–261. [CrossRef]
30. Iobbi, M.G.; Simonds, A.K.; Dickinson, R.J. Oximetry feedback flow control simulation for oxygen therapy.
J. Clin. Monit. Comput. 2007, 21, 115–123. [CrossRef]
31. El Adawi, M.I.; El-garhy, A.M.; Sawafta, F.O. Design of Fuzzy Controller for Supplying Oxygen in Sub-acute
Respiratory Illnesses. Int. J. Comput. Sci. Issues 2012, 9, 192–206.
32. Lellouche, F.; Bouchard, P.; Roberge, M.; Simard, S.; L’Her, E.; Maltais, F.; Lacass, Y. Automated oxygen
titration and weaning with FreeO2 in patients with acute exacerbation of COPD: A pilot randomized trial.
Int. J. COPD 2016, 11, 1983–1990. [CrossRef]
33. Cirio, S.; Nava, S. Pilot study of a new device to titrate oxygen flow in hypoxic patients on long-term oxygen
therapy. Respir. Care 2011, 56, 429–434. [CrossRef]
34. Rice, K.L.; Schmidt, M.F.; Buan, J.S.; Lebahn, F.; Schwarzock, T.K. AccuO2 Oximetry-Driven
Oxygen-Conserving Device Versus Fixed-Dose Oxygen Devices in Stable COPD Patients. Respir. Care 2011,
56, 1901–1905. [CrossRef]
35. Chan, E.D.; Chan, M.M.; Chan, M.M. Pulse oximetry: Understanding its basic principles facilitates
appreciation of its limitations. Respir. Med. 2013, 107, 789–799. [CrossRef] [PubMed]
36. Jacobs, S.S.; Lindell, K.O.; Collins, E.G.; Garvey, C.M.; Hernandez, C.; McLaughlin, S.; Schneidman, A.M.;
Meek, P.M. Patient perceptions of the adequacy of supplemental oxygen therapy: Results of the American
thoracic society nursing assembly oxygen working group survey. Ann. Am. Thorac. Soc. 2018, 15, 24–32.
[CrossRef] [PubMed]
37. Lara-Doña, A.; Sanchez-Morillo, D.; Pérez-Morales, M.; Fernandez-Granero, M.Á.; Leon-Jimenez, A. A
Prototype of Intelligent Portable Oxygen Concentrator for Patients with COPD Under Oxygen Therapy. In XV
Mediterranean Conference on Medical and Biological Engineering and Computing–MEDICON 2019; Henriques, J.,
Neves, N., de Carvalho, P., Eds.; Springer: Berlin/Heidelberg, Germany, 2020.
38. Branson, R.D. Oxygen therapy in copd. Respir. Care 2018, 63, 734–748. [CrossRef] [PubMed]
39. Dutta, A.; Ma, O.; Toledo, M.; Pregonero, A.; Ainsworth, B.; Buman, M.; Bliss, D. Identifying Free-Living
Physical Activities Using Lab-Based Models with Wearable Accelerometers. Sensors 2018, 18, 3893. [CrossRef]
40. Tedesco, S.; Barton, J.; O’Flynn, B. A Review of Activity Trackers for Senior Citizens: Research Perspectives,
Commercial Landscape and the Role of the Insurance Industry. Sensors 2017, 17, 1277. [CrossRef]
41. Rosenberg, D.; Godbole, S.; Ellis, K.; Di, C.; Lacroix, A.; Natarajan, L.; Kerr, J. Classifiers for
Accelerometer-Measured Behaviors in Older Women. Med. Sci. Sports Exerc. 2017, 49, 610–616. [CrossRef]
42. Farooq, M.; Sazonov, E. A Novel Wearable Device for Food Intake and Physical Activity Recognition. Sensors
2016, 16, 1067. [CrossRef]
43. Yang, C.-C.; Hsu, Y.-L. A review of accelerometry-based wearable motion detectors for physical activity
monitoring. Sensors 2010, 10, 7772. [CrossRef]
44. Inogen One G2 Oxygen Concentrator Technical Manual. Available online: https://www.inogen.com/pdf/
Inogen_One_G2_Technical_Manual.pdf (accessed on 11 October 2019).
45. Mortazavi, B.; Alsharufa, N.; Lee, S.I.; Lan, M.; Sarrafzadeh, M.; Chronley, M.; Roberts, C.K. MET calculations
from on-body accelerometers for exergaming movements. In Proceedings of the 2013 IEEE International
Conference on Body Sensor Networks, Cambridge, MA, USA, 6–9 May 2013.
46. Ainsworth, B.E.; Haskell, W.I.L.; Whitt, M.C.; Irwin, M.L.; Swartz, A.M.; Strath, S.J.; O’Brien, W.I.L.;
Bassett, D.R., Jr.; Schmitz, K.H.; Emplaincourt, P.O.; et al. Compendium of physical activities: An update of
activity codes and MET intensities. Med. Sci. Sports Exerc. 2000, 32, S498–S504. [CrossRef]
47. Kohavi, R.; John, G.H. Wrappers for feature subset selection. Artif. Intell. 1997, 97, 273–324. [CrossRef]
48. Casasent, D.; Wang, Y.C. A hierarchical classifier using new support vector machine for automatic target
recognition. Neural Netw. 2005, 18, 541–548. [CrossRef] [PubMed]
49. Wang, Y.-C.F.; Casasent, D. A support vector hierarchical method for multi-class classification and rejection.
In Proceedings of the 2009 International Joint Conference on Neural Networks, Atlanta, GA, USA,
14–19 June 2009.
Sensors 2020, 20, 1178 23 of 23
50. Brooke, J. SUS-A quick and dirty usability scale. Usabil. Eval. Ind. 1996, 189, 4–7.
51. Miłkowska-Dymanowska, J.; Białas, A.J.; Obre˛bski, W.; Górski, P.; Piotrowski, W.J. A pilot study of daily
telemonitoring to predict acute exacerbation in chronic obstructive pulmonary disease. Int. J. Med. Inform.
2018, 116, 46–51. [CrossRef] [PubMed]
52. Brooke, J. SUS: A Retrospective. J. Usabil. Stud. 2013, 8, 29–40.
53. Jacobs, S.S.; Lederer, D.J.; Garvey, C.M.; Hernandez, C.; Lindell, K.O.; McLaughlin, S.; Schneidman, A.M.;
Casaburi, R.; Chang, V.; Cosgrove, G.P.; et al. Optimizing Home Oxygen Therapy. An Official American
Thoracic Society Workshop Report. Ann. Am. Thorac. Soc. 2018, 15, 1369–1381. [CrossRef]
54. Marti, S.; Pajares, V.; Morante, F.; Ramon, M.-A.; Lara, J.; Ferrer, J.; Guell, M.-R. Are Oxygen-Conserving
Devices Effective for Correcting Exercise Hypoxemia? Respir. Care 2013, 58, 1606–1613. [CrossRef]
55. Scheeren, T.W.L.; Belda, F.J.; Perel, A. The oxygen reserve index (ORI): A new tool to monitor oxygen therapy.
J. Clin. Monit. Comput. 2018, 32, 379–389. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
